How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?

Wiktor Bzdęga,Piotr Franciszek Kurzyna,Ewa Harasim-Symbor,Adam Hołownia,Adrian Chabowski,Karolina Konstantynowicz-Nowicka

Nutrients（2023）

引用 0|浏览3

暂无评分

摘要

The results suggest that CBG treatment may modulate sphingolipid metabolism in the liver and plasma, potentially protecting the liver against the development of metabolic disorders such as insulin resistance.

查看译文

关键词

cannabigerol,ceramide,sphingolipid metabolism,insulin resistance,metabolic disorders,liver

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要